[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biogen Inc (BIIB)

Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,560,376
  • Shares Outstanding, K 147,637
  • Annual Sales, $ 9,891 M
  • Annual Income, $ 1,293 M
  • EBIT $ 2,420 M
  • EBITDA $ 3,493 M
  • 60-Month Beta 0.19
  • Price/Sales 2.86
  • Price/Cash Flow 8.46
  • Price/Book 1.51

Options Overview Details

View History
  • Implied Volatility 33.74% (+2.88%)
  • Historical Volatility 35.56%
  • IV Percentile 40%
  • IV Rank 26.56%
  • IV High 50.85% on 10/16/25
  • IV Low 27.55% on 01/07/26
  • Expected Move (DTE 5) 6.62 (3.42%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 1,624
  • Volume Avg (30-Day) 1,888
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 54,504
  • Open Int (30-Day) 51,770
  • Expected Range 186.83 to 200.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 34 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $3.52
  • Number of Estimates 23
  • High Estimate $4.75
  • Low Estimate $2.83
  • Prior Year $5.47
  • Growth Rate Est. (year over year) -35.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
171.22 +12.98%
on 04/13/26
195.98 -1.29%
on 04/30/26
+13.55 (+7.53%)
since 04/08/26
3-Month
168.64 +14.71%
on 04/06/26
201.00 -3.76%
on 02/09/26
-7.73 (-3.84%)
since 02/06/26
52-Week
118.05 +63.87%
on 05/09/25
202.41 -4.43%
on 02/06/26
+75.06 (+63.40%)
since 05/08/25

Most Recent Stories

More News
Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease

TOKYO and CAMBRIDGE, Mass. , May 8, 2026 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period...

BIIB : 193.45 (+1.08%)
3 Value Stocks We Approach with Caution

3 Value Stocks We Approach with Caution

GTM : 6.38 (-3.77%)
LEVI : 22.67 (-0.35%)
BIIB : 193.45 (+1.08%)
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600

NEW YORK , May 7, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Thursday, May 14:

RELY : 24.03 (+5.44%)
APLS : 41.03 (+0.05%)
SPGI : 420.12 (-2.00%)
TPH : 46.95 (unch)
BIIB : 193.45 (+1.08%)
BFAM : 70.59 (+3.34%)
Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates

– New 4-year longitudinal data from the Phase 1/2a open-label extension (OLE) studies provide additional support for the disease-modifying potential of zorevunersen, an investigational medicine for the...

STOK : 32.89 (+0.30%)
BIIB : 193.45 (+1.08%)
Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational...

STOK : 32.89 (+0.30%)
BIIB : 193.45 (+1.08%)
Biogen (NASDAQ:BIIB) Surprises With Q1 CY2026 Sales

Biogen (NASDAQ:BIIB) Surprises With Q1 CY2026 Sales

BIIB : 193.45 (+1.08%)
Biogen's Turnaround Thesis Hangs on Whether New Products Can Offset the MS Decline

Barchart Research What to Expect from BIIB Earnings BIIB Generated April 28, 2026 Current Price $183.38 EPS Estimate $$2.96 Consensus Rating Moderate Buy Average Move 2.80% Biogen's Turnaround Thesis Hangs...

BIIB : 193.45 (+1.08%)
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

BIIB : 193.45 (+1.08%)
3 Profitable Stocks We Steer Clear Of

3 Profitable Stocks We Steer Clear Of

NOC : 549.52 (-0.50%)
BYD : 85.64 (+0.47%)
BIIB : 193.45 (+1.08%)
Stocks making big moves yesterday: Cadence Design Systems, JFrog, Lucid, Ulta, and Biogen

Stocks making big moves yesterday: Cadence Design Systems, JFrog, Lucid, Ulta, and Biogen

LCID : 6.34 (+4.79%)
ULTA : 521.58 (-0.94%)
FROG : 70.55 (+23.73%)
CDNS : 362.70 (+1.63%)
BIIB : 193.45 (+1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement...

See More

Key Turning Points

3rd Resistance Point 201.63
2nd Resistance Point 198.42
1st Resistance Point 195.93
Last Price 193.45
1st Support Level 190.23
2nd Support Level 187.02
3rd Support Level 184.53

See More

52-Week High 202.41
Last Price 193.45
Fibonacci 61.8% 170.18
Fibonacci 50% 160.23
Fibonacci 38.2% 150.28
52-Week Low 118.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.